Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,057Revenue $M1,996Net Margin (%)4.8Z-Score3.7
Enterprise Value $M3,056EPS $1.6Operating Margin %6.8F-Score8
P/E(ttm))26.0Cash Flow Per Share $2.2Pre-tax Margin (%)6.7Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %16.0Quick Ratio1.5Cash flow > EarningsY
Price/Sales1.45-y EBITDA Growth Rate %9.7Current Ratio1.6Lower Leverage y-yY
Price/Cash Flow14.5y-y EBITDA Growth Rate %45.0ROA % (ttm)5.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)17.8Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M56.2ROI % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with PRXL

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PRXLJoel Greenblatt 2014-03-31 Add0.07%$45.18 - $56.94
($51.01)
$ 53.755%Add 361.66%103,542
PRXLVanguard Health Care Fund 2013-12-31 Add0.26%$38.93 - $54.85
($45.69)
$ 53.7518%Add 63.66%4,805,700
PRXLJoel Greenblatt 2013-12-31 Reduce-0.04%$38.93 - $54.85
($45.69)
$ 53.7518%Reduce -51.75%22,428
PRXLJoel Greenblatt 2013-09-30 Reduce-0.12%$46.43 - $51.33
($48.98)
$ 53.7510%Reduce -57.22%46,486
PRXLJoel Greenblatt 2013-03-31 Reduce-0.07%$29.59 - $39.54
($34.89)
$ 53.7554%Reduce -25.52%115,560
PRXLJoel Greenblatt 2012-09-30 Add0.11%$26.98 - $31.09
($28.66)
$ 53.7588%Add 64.33%139,526
PRXLJoel Greenblatt 2012-06-30 Add0.05%$25 - $28.38
($26.43)
$ 53.75103%Add 37.93%84,905
PRXLJoel Greenblatt 2012-03-31 Add0.09%$20.46 - $28.22
($22.66)
$ 53.75137%Add 165.31%61,558
PRXLJoel Greenblatt 2011-12-31 Buy 0.06%$18.26 - $22.63
($20.17)
$ 53.75166%New holding, 23202 sh.23,202
PRXLGeorge Soros 2011-03-31 Sold Out $19.96 - $25.06
($22.45)
$ 53.75139%Sold Out0
PRXLGeorge Soros 2010-12-31 Buy $17.49 - $22.65
($20.62)
$ 53.75161%New holding, 10000 sh.10,000
PRXLGeorge Soros 2010-09-30 Sold Out -0.01%$19.84 - $24.61
($21.76)
$ 53.75147%Sold Out0
PRXLGeorge Soros 2010-06-30 Buy 0.01%$19.8 - $25.16
($23.03)
$ 53.75133%New holding, 17000 sh.17,000
PRXLMartin Whitman 2008-01-31 Sold Out -0.26%$22.08 - $28.5
($24.5)
$ 53.75119%Sold Out0
PRXLMeridian Funds 2004-12-31 Sold Out $9.08 - $10.53
($10)
$ 53.75438%eliminated -- 38 500 sh.0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PRXL is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PRXL Joel Greenblatt 2014-03-31103,5420.180.08+361.66%
PRXL Vanguard Health Care Fund 2014-03-314,805,7008.550.73
Premium Most recent portfolio changes are included for Premium Members only!


PRXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FORTUNE PATRICK JDirector 2014-06-05Sell3,000$53.041.98view
FORTUNE PATRICK JDirector 2014-03-24Sell1,388$53.680.76view
Cooper AnitaSenior VP, CRS 2014-02-20Sell2,500$532.06view
GOLDBERG MARK APresident & COO 2014-02-18Sell11,206$52.493.05view
GOLDBERG MARK APresident & COO 2014-02-12Sell12,199$50.497.13view
Cooper AnitaSenior VP, CRS 2014-02-11Sell10,000$508.18view
VON RICKENBACH JOSEF HChairman & CEO 2014-02-10Sell50,000$49.768.7view
CALLOW A DANA JRDirector 2014-02-10Sell10,000$49.49.49view
Holdener Eduard E.Director 2014-02-10Sell6,000$49.629.01view
VON RICKENBACH JOSEF HChairman & CEO 2014-02-07Sell50,000$49.78.83view

Press Releases about PRXL :

    Quarterly/Annual Reports about PRXL:

    News about PRXL:

    Articles On GuruFocus.com
    Parexcel: Great Growth but a Tough Business Aug 17 2011 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 12,920 Shares Mar 11 2011 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 1,500 Shares Mar 11 2011 
    PAREXEL International Corp. Reports Operating Results (10-Q) Feb 09 2011 
    PAREXEL International Corp. Reports Operating Results (10-Q) Nov 09 2010 
    PAREXEL International Corp. Reports Operating Results (10-K/A) Sep 09 2010 
    PAREXEL International Corp. Reports Operating Results (10-K) Aug 27 2010 
    PAREXEL International Corp. Reports Operating Results (10-Q) May 07 2010 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 13,149 Shares Mar 12 2010 
    PAREXEL International Corp. (PRXL) Senior VP & CFO James F Jr Winschel sells 15,600 Shares Mar 04 2010 

    More From Our Partners
    Bull of the Day: PAREXEL (PRXL) - Bull of the Day Jul 10 2014 - ZACKS

    More From Other Websites
    Zacks' Bull Of The Day: PAREXEL Jul 10 2014
    PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2014 Earnings Release And... Jul 10 2014
    PAREXEL International, Darden Restaurants, Baker Hughes, Helmerich & Payne and Patterson-UTI Energy... Jul 10 2014
    Bull of the Day: PAREXEL (PRXL) Jul 10 2014
    PAREXEL Up on Acquisition of Clinical Research Company Jul 07 2014
    Is PARAXEL International (PRXL) a Great Growth Stock? Jul 07 2014
    On The Fly: Analyst Initiation Summary Jul 03 2014
    PAREXEL acquires ATLAS Medical Services Jul 01 2014
    PAREXEL International Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical... Jul 01 2014
    Parexel Defended After Post-Guidance Sell-Off Jun 26 2014
    Will These Analyst Actions Help Parexel International (PRXL) Stock Today? Jun 26 2014
    PAREXEL upgraded to Outperform at RW Baird Jun 26 2014
    PAREXEL added to Priority Stock List at Wells Fargo Jun 26 2014
    PAREXEL upgraded by Robert W. Baird Jun 26 2014
    Will This Price Target Increase Help Parexel International (PRXL) Stock Today? Jun 25 2014
    PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day Jun 24 2014
    PAREXEL Named 2014 Best Performing CRO In Taiwan For Drug Development And Healthcare Industry... Jun 23 2014
    PAREXEL Wins 2014 IABC Gold Quill Merit Award For Internal Communications Jun 19 2014
    PAREXEL's ClinPhone RTSM Cuts Clinical Trial Start-Up Time Jun 18 2014
    PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jun 18 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide